Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12358968
Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer
granted -
US 12357599
Prodrugs of treprostinil
granted -
US 12357705
Negatively charged peg-lipid conjugates
granted -
US 12357582
Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations
granted -
US 12357586
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
granted -
US 12358863
Nitrogen-containing derivative of substituted phenol hydroxy acid ester, and preparation and use thereof
granted -
US 12358928
Compounds, compositions and methods
granted -
US 12357623
Method for treating a disease or condition using a pyrazole compound or formulation thereof
granted -
US 12357590
Binge behavior regulators
granted -
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted -
US 12358885
Substituted n-propylamine fused heterocyclic mescaline derivatives
granted -
US 12357598
Treatment of neurodevelopmental disorders
granted -
US 12358971
Arena virus monoclonal antibodies and uses
granted -
US 12357570
Chemoembolization agents
granted -
US 12358952
Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds
granted -
US 12359223
Systems and methods for modulating chromosomal rearrangements
granted -
US 12359220
Guided magnetic nanostructures for targeted and high-throughput intracellular delivery
granted -
US 12357555
Self-emulsifying composition, intended for administration onto the skin, containing biosurfactant, cosurfactant and oil phase
granted -
US 12357604
Topical formulations of cannabinoids and use thereof in the treatment of pain
granted -
US 12357682
DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA
granted -
US 12359178
Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase
granted -
US 12359204
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12358931
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
granted -
US 12357615
Compositions for the treatment of brain tumors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.